(Total Views: 339)
Posted On: 11/12/2019 4:22:44 PM
Post# of 145915
We are close to reaching the point that Cytodyn can't be ignored. Mono or cancer makes leronlimab a billion dollar drug. Cydy is asking for $90M + commercialization for 50% cut. BP is not use to giving that big of a cut, but 50% of a billion dollar drug is better than 80% of nothing. That is why cydy is selling, which the science continues to support.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)